Recent concepts of ovarian carcinogenesis: type I and type II - Wikidata - wikimedia - TriplyDB

Recent concepts of ovarian carcinogenesis: type I and type II

Recent concepts of ovarian carcinogenesis: type I and type II

http://www.wikidata.org/entity/Q27009487

about

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer Emerging and Evolving Ovarian Cancer Animal Models Lesser-Known Molecules in Ovarian Carcinogenesis Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.Molecular genetics complexity impeding research progress in breast and ovarian cancers.Melatonin for the prevention and treatment of cancer Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.Estrogen biosynthesis and action in ovarian cancer.Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.A novel hysteroscopic approach for ovarian cancer screening/early diagnosis.An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis Expression of the MT1 melatonin receptor in ovarian cancer cells.Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.Clinical Efficacy of Ovarian Cancer Screening.Ovarian cancer: involvement of the matrix metalloproteinases.FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.Subtypes of Ovarian Cancer and Ovarian Cancer Screening.Malignant Transformation of Pelvic Endometriosis: Case Series and Review of the Literature.Transverse Relaxation Rate of Cyst Fluid Can Predict Malignant Transformation of Ovarian Endometriosis.Epigenetic and genetic dispositions of ovarian carcinomas Screening for ovarian cancer: imaging challenges and opportunities for improvement.The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.Hormone-receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria.High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer.Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review.Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.Cytomorphology of ovarian clear cell carcinomas in peritoneal effusions.Discrimination of malignant transformation from benign endometriosis using a near-infrared approach.STAT3/PIAS3 levels serve as "early signature" genes in the development of high-grade serous carcinoma from the fallopian tube.BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer.CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer.Mucinous epithelial tumours arising from ovarian mature teratomas: a tissue genotyping study.The shading sign: is it exclusive of endometriomas?Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients.

P2860

Q26777702-062C27A8-F18B-477D-96DC-D564ACC2365B Q26783909-B7920EBD-7C11-44FD-9A6D-4A780D31FC44 Q26784533-34EBD8EF-30D8-42F3-BA4D-C27DAB1E16CB Q33624824-8A5E8F1A-203D-47B3-8708-7BE26ADF4A07 Q33850475-D933BB8F-B729-479D-8540-E22437DB32E9 Q33858073-982A1103-6B84-4258-A810-3EC435B4FCBE Q33889427-185DF635-CE90-48AA-AAC8-C7D9F7A13C84 Q33983058-E4F1400D-8621-47B9-95DF-CBEB27BF49B0 Q34496401-9FD57102-E6EB-4B8F-B231-5FD3E60073C0 Q34528553-30CAEAC8-E7CB-40DA-AA19-E83C8E2FDFB0 Q34554394-AFCFB87D-B6AF-4FCC-91DC-F3A71B766F82 Q34558361-38DF07CD-C692-44F4-97E4-2C3F30187D7F Q34835245-822C54F9-EDCF-4A9D-B551-303CD6786CE5 Q35038444-1CB72E25-B3BB-492C-8E43-B004A296C900 Q36546449-C62174F6-9185-469A-BEE8-5F50214ADDC5 Q36592537-ED1AE992-AF9C-47EF-B2E7-F181561BF813 Q37068015-CA224536-7171-4D6F-B23A-63C6AA1695C7 Q37113828-CA42D6B2-ED09-4308-B3F4-BB8295C96F35 Q37375225-CD0D436E-132B-4FFB-92C7-2C845ACD85F3 Q37696086-D4DF2AF7-0145-4DF5-AF21-55826EA871F4 Q37729974-7FDCD67A-2532-4BE8-BBE9-ABD462AABBA5 Q38441719-B50A57D3-104A-4720-9D9F-CC18B21D0912 Q39373334-6F76AFC5-667E-4B4D-8CCB-B8B518A4D933 Q42112898-4F9E8027-BAEC-46E6-B0B5-A9E355A43E26 Q43557526-00047FD3-75DF-4DAD-85D8-FBA7C01F80EF Q46304569-D8A5CA45-2088-4890-8D48-A7EFADE4789F Q46747718-1377D01D-5E9C-44B2-A617-0AC2B1BCE527 Q46983404-3702DD2C-3444-4FC0-9E19-27FB057579BF Q47142893-0258CEF6-A2B9-46B8-89AF-247DCBA99DE1 Q47969294-CD58685F-7A2F-43B5-B795-7F4D0FF996F7 Q48625336-AAB2CC1E-9665-4B8A-B92E-19C6EEC36349 Q48857209-C33B16E5-C1AE-43B5-A13C-654D315AA970 Q49875204-142BF1F6-4A8B-4D2F-A859-54703D709F8C Q50020012-CDBD3511-4F92-44FD-BB21-73FA4E0B5325 Q52715784-CE35D0B2-72FA-422E-9FDE-FEE93416AAC9 Q52728031-1412EC29-0311-408F-ABBA-023ACD5C4F97 Q53154252-511DA2F4-F188-4EFE-B6C5-2221A61523AF Q53471977-363AC9B1-E6AF-4568-9C0E-220D7F7BA111 Q55230761-9A601C76-6399-4AF4-AF6E-54E3A8202F5E

P2860

Recent concepts of ovarian carcinogenesis: type I and type II

http://www.wikidata.org/entity/Q27009487

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Recent concepts of ovarian carcinogenesis: type I and type II

@ast

Recent concepts of ovarian carcinogenesis: type I and type II

@en

Recent concepts of ovarian carcinogenesis: type I and type II

@nl

type

label

Recent concepts of ovarian carcinogenesis: type I and type II

@ast

Recent concepts of ovarian carcinogenesis: type I and type II

@en

Recent concepts of ovarian carcinogenesis: type I and type II

@nl

prefLabel

Recent concepts of ovarian carcinogenesis: type I and type II

@ast

Recent concepts of ovarian carcinogenesis: type I and type II

@en

Recent concepts of ovarian carcinogenesis: type I and type II

@nl

P1433

Q27009487-F64A70A5-DFB4-46F4-A103-D22DEDB08394

P1476

Q27009487-20EAE921-4744-4F05-8F1B-1C5D7B193B02

P2093

Q27009487-65563432-7DE7-4742-A145-9D6D7AFE736C

Q27009487-6A214A2E-ECD7-477F-8A36-9935A4AA4A33

P275

Q27009487-1A5C2335-E2D2-4097-BD2B-2C7FDC4FD7BF

P2860

Q27009487-035702C4-9538-46F5-95A8-F39CFAAF393A

Q27009487-05697FAE-C0C1-422C-8841-6EA9E0790FB8

Q27009487-05CABF82-837E-43F7-815F-F4C6499CBAF7

Q27009487-0B086360-7BD5-4A83-9E5E-FF16EC0A697D

Q27009487-0EF40843-E512-4B76-AD6C-89193FE04A4E

Q27009487-0F583296-89A4-4DBD-B29E-F7A7599FB678

Q27009487-12F51A23-C4E4-439A-A6CD-79D1AF244AD0

Q27009487-13DCCE51-B49D-40A7-B937-A4DF21814827

Q27009487-1A1692D0-4CED-4ADA-BA63-7B2109149094

Q27009487-20594AC1-CDD9-43C9-B3E2-9108BB59CC7A

P304

Q27009487-3DDD29F4-4180-4DA9-943D-D772B8C04A43

P31

Q27009487-6C579EB1-7AC6-4F92-A1DB-2D8970FB9A39

Q27009487-CA88A2F1-77F5-43A5-BE87-DEE888264DA0

P3181

Q27009487-828F74C0-9407-4829-A720-A03949051154

P356

Q27009487-A99E56FE-47C4-4F3E-A9FC-6F2BEB490753

P407

Q27009487-FDD7F131-9B70-4137-92C5-07F7C88A6A54

P478

Q27009487-6531A9AE-D6E5-4693-A7D0-209068849713

P50

Q27009487-4A163F8A-B3BA-423D-B77B-05C688B49DCC

P5008

Q27009487-028CBF9C-DB75-49DC-98CF-3C3A1AFD44FB

P577

Q27009487-D3AEF95A-37F2-4DD8-BF29-A2674A4608EC

P5875

Q27009487-33126DE0-E8B7-4709-9D56-A16627EC72F3

P698

Q27009487-E634AB1B-B910-409B-89A6-CC796934D175

P921

Q27009487-A9C277BE-E2CF-45C5-94D5-7230BB02C4D2

P932

Q27009487-0F3239EF-0FF0-4EFA-BA2F-A6D77F4B314C

P3181

P356

P1433

BioMed Research International

P1476

Recent concepts of ovarian carcinogenesis: type I and type II

@en

P2093

Ikuo Konishi

http://www.w3.org/2001/XMLSchema#string

Masafumi Koshiyama

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Global cancer statistics

ARID1A mutations in endometriosis-associated ovarian carcinomas

Integrated genomic analyses of ovarian carcinoma

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy

The cell of origin of ovarian epithelial tumours

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.

Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.

Whole exome sequence analysis of serous borderline tumors of the ovary.

P304

934261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

489299

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2014/934261

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Noriomi Matsumura

P5008

P577

2014-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262680400

http://www.w3.org/2001/XMLSchema#string

P698

24868556

http://www.w3.org/2001/XMLSchema#string

P921

P932

4017729

http://www.w3.org/2001/XMLSchema#string